Post Profile

The Promise of TMS: Interview with Neuronetics Chief Medical Officer Mark Demitrack, M.D.

Transcranial magnetic stimulation (TMS) has been studied as a potential therapy for disorders ranging from drug addiction to bipolar disease. The premise is that pulsed, MRI-grade magnetic fields can locally excite or inhibit regions of the cerebral cortex, thus affecting neurological function. The makers of the NeuroStar TMS System, Neuronetics, contacted us to let us know about their new study released at the American Psychiatric Association meeting in May.
read more


Related Posts

Is Magnetic Therapy Effective for Tinnitus?

Health : Newswise Medical News

Researchers are studying whether a new non-invasive magnetic therapy can help people who suffer debilitating tinnitus (ringing in the ears). Transcranial magnetic stimulation (TMS), sends short pulses of magnetic fields to the brain...

Neuronetics’ NeuroStar TMS for Major Depressive Disorder Cleared in Europe

Industries / Medical : medGadget

Neuronetics (Malvern, PA) received the European CE Mark to bring its NeuroStar transcranial magnetic stimulation (TMS) system across the pond. It has been approved for use in the U.S. for about for years now. Only two days ago we pu...

Neuronetics TMS Depression Therapy Gets FDA OK

Industries / Medical : medGadget

Neuronetics, a Malvern, Pennsylvania company, has won FDA's first approval for a transcranial magnetic stimulation (TMS) system for treatment of depression in patients that don't respond to drug therapy. This is a huge step for a te...

Brainsway’s Transcranial Magnetic Stimulation to Go on Trial for Bipolar Disorder

Industries / Medical : medGadget

Transcranial magnetic stimulation (TMS) has been a promising new technology that’s been undergoing trials for such disparate conditions as depression, smoking cessation, ADD, Alzheimer’s, cocaine addiction, and multiple sclerosis. N...

New Data Show No Negative Long-Term Effect In Cognitive Function In Patients With Major Depressive Disorder Treated With NeuroStar TMS Therapy(R)

Health : Medical News Today

In an open-label study of patients with major depressive disorder (MDD) who had not benefitted from prior antidepressant medication and were treated with Neuronetics' NeuroStar Transcranial Magnetic Stimulation (TMS) Therapy, no neg...


Copyright © 2016 Regator, LLC